Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,059 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study.
Morishita A, Oura K, Takuma K, Nakahara M, Tadokoro T, Fujita K, Tani J, Shi T, Himoto T, Tatsuta M, Moriya A, Senoo T, Tsutsui A, Nagano T, Takaguchi K, Ono M, Masaki T. Morishita A, et al. Among authors: fujita k. Hepatol Int. 2023 Jun;17(3):606-614. doi: 10.1007/s12072-022-10453-1. Epub 2022 Dec 30. Hepatol Int. 2023. PMID: 36583842 Free PMC article.
Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease.
Yoneda M, Hotta K, Nozaki Y, Endo H, Tomeno W, Watanabe S, Hosono K, Mawatari H, Iida H, Fujita K, Takahashi H, Kirikoshi H, Kobayashi N, Inamori M, Kubota K, Shimamura T, Saito S, Maeyama S, Wada K, Nakajima A. Yoneda M, et al. Among authors: fujita k. Hepatol Res. 2009 Oct;39(10):963-71. doi: 10.1111/j.1872-034X.2009.00539.x. Epub 2009 Jul 13. Hepatol Res. 2009. PMID: 19624767
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.
Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Fujita K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Sumida Y, et al. Among authors: fujita k. BMC Gastroenterol. 2012 Jan 5;12:2. doi: 10.1186/1471-230X-12-2. BMC Gastroenterol. 2012. PMID: 22221544 Free PMC article.
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.
Miyoshi H, Kato K, Iwama H, Maeda E, Sakamoto T, Fujita K, Toyota Y, Tani J, Nomura T, Mimura S, Kobayashi M, Morishita A, Kobara H, Mori H, Yoneyama H, Deguchi A, Himoto T, Kurokohchi K, Okano K, Suzuki Y, Murao K, Masaki T. Miyoshi H, et al. Among authors: fujita k. Int J Oncol. 2013 Dec 30. doi: 10.3892/ijo.2013.2233. Online ahead of print. Int J Oncol. 2013. PMID: 24378856
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.
Miyoshi H, Kato K, Iwama H, Maeda E, Sakamoto T, Fujita K, Toyota Y, Tani J, Nomura T, Mimura S, Kobayashi M, Morishita A, Kobara H, Mori H, Yoneyama H, Deguchi A, Himoto T, Kurokohchi K, Okano K, Suzuki Y, Murao K, Masaki T. Miyoshi H, et al. Among authors: fujita k. Int J Oncol. 2014 Jul;45(1):322-32. doi: 10.3892/ijo.2014.2419. Epub 2014 May 6. Int J Oncol. 2014. PMID: 24806290
Ethanol injection therapy for small hepatocellular carcinomas located beneath a large vessel using a curved percutaneous ethanol injection therapy needle.
Watanabe S, Morishita A, Deguchi A, Nakai S, Sakamoto T, Fujita K, Maeda E, Nomura T, Tani J, Miyoshi H, Yoneyama H, Fujiwara S, Kobara H, Mori H, Himoto T, Masaki T. Watanabe S, et al. Among authors: fujita k. Oncol Lett. 2014 Jun;7(6):1831-1834. doi: 10.3892/ol.2014.2053. Epub 2014 Apr 9. Oncol Lett. 2014. PMID: 24932242 Free PMC article.
5,059 results